Please assess the completion status of the following clinical trial:

Trial Title: Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients diagnosed as having cirrhosis of liver at the Inpatient/Outpatient Liver Clinic of Department of Hepatology, PGIMER, Chandigarh, will be candidates for enrollment.~* The diagnosis of cirrhosis of liver will be based on clinical, biochemical, and ultrasonographical or liver histological data.~Exclusion Criteria:~* Alcohol intake during the past 6 weeks~* Hepatocellular carcinoma~* Previous transjugular intrahepatic portosystemic shunt or shunt surgery~* Significant comorbid illness such as heart, respiratory, or renal failure~* Any neurologic diseases such as Alzheimer's disease, Parkinson's disease, and nonhepatic metabolic encephalopathies.~* Patients on psychoactive drugs, such as antidepressants or sedatives~* Those who restart alcohol consumption during follow-up will also be excluded.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- VSL#3 (Type: EXPERIMENTAL): VSL#3® is made up of 4 strains of Lactobacilli (L. paracasei, L. plantarum, L. acidophilus and L. delbrueckii subsp. bulgaricus), 3 strains of Bifidobacteria (B. longum, B. infantis, B. breve) and 1 strain of Streptococcus thermophilus.
- Placebo (Type: PLACEBO_COMPARATOR): Placebo sachets contain corn starch

Based on this trial design, predict the completion outcome and termination type (if applicable).